- In October 2018, RPS Diagnostics, Inc reported that its FebriDx test had gained the CE mark. Within 10 minutes, doctors will be able to examine the body's immune response to an acute respiratory infection using a fingerstick blood sample. This device was created specifically to detect various conditions and ARI.
Frequently Asked Questions
The market is segmented based on Global C-Reactive Protein Testing Market Segmentation, By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others), Detection Range (hs-CRP, Conventional CRP, cCRP), Disease (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Syphilis, Inflammatory Diseases, Diabetes, Others), Analysis Mode (Serum, Plasma, Blood), End-User (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others), Product Type (Kits, Reagents) - Industry Trends and Forecast to 2032
.
The Global C Reactive Protein Testing Market size was valued at USD 5.72 USD Billion in 2024.
The Global C Reactive Protein Testing Market is projected to grow at a CAGR of 1.15% during the forecast period of 2025 to 2032.
The major players operating in the market include Thermo Fisher ScientificInc. , F. Hoffmann-La Roche Ltd. , Danaher , Quest Diagnostics Incorporated , Siemens Healthineers AG , Abbott , Merck KGaAA , Zoetis , Ortho Clinical Diagnostics , Getein BiotechInc. , HORIBALtd , Randox Laboratories Ltd. , BODITECH MEDInc. , Aidian .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
